CD274 and non-small cell lung carcinoma: Herbst Herbst RS RS Giaccone Giaccone G G de Marinis de Marinis F F Reinmuth Reinmuth N N Vergnenegre Vergnenegre A A Barrios Barrios CH CH Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC N Engl J Med N Engl J Med 2020 2020 383 383 1328 1328 39 39 10.1056/nejmoa1917346 10.1056/nejmoa1917346 32997907 32997907